Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide.
Eghtedar A, Rodriguez I, Kantarjian H, O'Brien S, Daver N, Garcia-Manero G, Ferrajoli A, Kadia T, Pierce S, Cortes J, Ravandi F. Eghtedar A, et al. Among authors: ferrajoli a. Leuk Lymphoma. 2015 May;56(5):1342-5. doi: 10.3109/10428194.2014.953143. Epub 2014 Nov 3. Leuk Lymphoma. 2015. PMID: 25120050 Free PMC article.
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes.
Benjamini O, Jain P, Trinh L, Qiao W, Strom SS, Lerner S, Wang X, Burger J, Ferrajoli A, Kantarjian H, O'Brien S, Wierda W, Estrov Z, Keating M. Benjamini O, et al. Among authors: ferrajoli a. Leuk Lymphoma. 2015 Jun;56(6):1643-50. doi: 10.3109/10428194.2014.957203. Epub 2014 Nov 19. Leuk Lymphoma. 2015. PMID: 25308294 Free PMC article.
A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia.
Strati P, Tong WG, Vitale C, Wierda WG, O'Brien S, Brown JR, Weng WK, Kipps T, Keating MJ, Ferrajoli A. Strati P, et al. Among authors: ferrajoli a. Leuk Lymphoma. 2015 Jun;56(6):1878-80. doi: 10.3109/10428194.2014.974049. Epub 2014 Nov 20. Leuk Lymphoma. 2015. PMID: 25311497 Free PMC article. Clinical Trial. No abstract available.
Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia.
Maiti A, Cortes J, Ferrajoli A, Estrov Z, Borthakur G, Garcia-Manero G, Jabbour E, Ravandi F, O'Brien S, Kantarjian H. Maiti A, et al. Among authors: ferrajoli a. Leuk Lymphoma. 2017 Sep;58(9):1-6. doi: 10.1080/10428194.2017.1283030. Epub 2017 Feb 9. Leuk Lymphoma. 2017. PMID: 28278723 Free PMC article. Clinical Trial. No abstract available.
360 results